CLOFAZIMINE

✅ CLOFAZIMINE (CAS 2030-63-9) – PRODUCT DESCRIPTION

Clofazimine (CAS 2030-63-9) is a synthetic antimicrobial agent that belongs to the riminophenazine class. It is primarily used in the treatment of leprosy and multidrug-resistant tuberculosis (MDR-TB). Clofazimine works by inhibiting the growth of bacteria and parasites, especially those resistant to other antibiotics. It has anti-inflammatory properties and is often used in combination with other antibiotics for the treatment of leprosy. It can also be used as part of tuberculosis treatment regimens, particularly in cases of drug-resistant strains. This red to brown crystalline powder is available in pharmaceutical grades, ensuring high purity for use in oral formulations and injection preparations. We supply Clofazimine to pharmaceutical manufacturers, healthcare providers, and research organizations globally, ensuring a reliable and high-quality supply to USA, Malaysia, Vietnam, and Chile.

📦 Industries Used In:

• Pharmaceuticals (treatment of leprosy, MDR-TB, and drug-resistant tuberculosis)

• Healthcare (management of bacterial infections and inflammatory skin diseases)

• Research (studies on antimicrobial resistance, tuberculosis treatments, and leprosy management)

• Manufacturing (production of oral tablets and injectable solutions for tuberculosis and leprosy)

🧪 Available Grades:

• Pharmaceutical Grade

• Reagent Grade

• Laboratory Grade

⚙️ Functions:

• Antimicrobial agent used in the treatment of leprosy and drug-resistant tuberculosis

• Inhibits bacterial growth, particularly in MDR-TB and leprosy cases

• Anti-inflammatory properties, beneficial in managing leprosy-associated skin conditions

• Effective against multidrug-resistant tuberculosis

• Reagent in infectious disease research and antimicrobial therapy studies

🧩 Classified Under:

• Pharmaceuticals

• Antimicrobial Agents

• Leprosy and Tuberculosis Medications

• Active Pharmaceutical Ingredients (APIs)

• Anti-inflammatory Agents